NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells

Circ Res. 2009 Sep 11;105(6):537-44. doi: 10.1161/CIRCRESAHA.109.205138. Epub 2009 Aug 13.

Abstract

Rationale: Endothelial progenitor cells (EPCs, defined as sca-1(+)flk-1(+)lin(-) mononuclear blood cells) contribute to vascular repair. The role of hypoxia and reactive oxygen species (ROS) in mobilization and function of these cells is incompletely understood.

Objective: We studied the contribution of the NADPH oxidase Nox2, an important vascular source of ROS in this context.

Methods and results: Hypoxia (10% oxygen) induced the mobilization of EPCs in wild-type (WT) and Nox1 but not in Nox2 knockout (Nox2(y/-)) mice. As erythropoietin (EPO) is known to induce EPC mobilization, we focused on this hormone. EPO induced the mobilization of EPCs in WT and Nox1(y/-) but not Nox2(y/-) animals. Transplantation of bone marrow from Nox2(y/-) mice into WT-mice blocked mobilization in response to hypoxia and EPO, whereas transplantation of WT bone marrow into Nox2(y/-) mice restored mobilization. Reendothelialization of the injured mouse carotid artery was enhanced by hypoxia as well as by EPO, and this effect was not observed in Nox2(y/-) mice or after transplantation of Nox2(y/-) bone marrow. In cultured EPCs from WT but not Nox2(y/-) mice, EPO induced ROS production, migration, and proliferation. EPO signaling involves the STAT5 transcription factor. EPO-induced STAT5-dependent reporter gene expression was absent in Nox2-deficient cells. siRNA against the redox-sensitive phosphatase SHP-2 restored EPO-mediated STAT5 induction and inhibition of SHP-2 restored EPO-induced migration in Nox2-deficient cells

Conclusions: We conclude that Nox2-derived ROS inactivate SHP-2 and thereby facilitate EPO signaling in EPCs to promote hypoxia-induced mobilization and vascular repair by these cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Ly
  • Bone Marrow Transplantation
  • Carotid Arteries / enzymology
  • Carotid Arteries / pathology
  • Carotid Artery Injuries / enzymology
  • Carotid Artery Injuries / genetics
  • Carotid Artery Injuries / pathology
  • Cells, Cultured
  • Endothelial Cells / enzymology*
  • Endothelial Cells / pathology
  • Erythropoietin / metabolism
  • Gene Expression Regulation / genetics
  • Hypoxia / enzymology*
  • Hypoxia / genetics
  • Hypoxia / pathology
  • Leukocytes, Mononuclear / enzymology*
  • Leukocytes, Mononuclear / metabolism
  • Leukocytes, Mononuclear / pathology
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism*
  • Membrane Proteins
  • Mice
  • Mice, Knockout
  • NADH, NADPH Oxidoreductases / genetics
  • NADH, NADPH Oxidoreductases / metabolism
  • NADPH Oxidase 1
  • NADPH Oxidase 2
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11 / metabolism
  • Reactive Oxygen Species / metabolism
  • STAT5 Transcription Factor / metabolism
  • Signal Transduction / genetics
  • Stem Cells / enzymology*
  • Stem Cells / pathology
  • Vascular Endothelial Growth Factor Receptor-2
  • Wound Healing / genetics

Substances

  • Antigens, Ly
  • Ly6a protein, mouse
  • Membrane Glycoproteins
  • Membrane Proteins
  • Reactive Oxygen Species
  • STAT5 Transcription Factor
  • Erythropoietin
  • NADH, NADPH Oxidoreductases
  • Cybb protein, mouse
  • NADPH Oxidase 1
  • NADPH Oxidase 2
  • NADPH Oxidases
  • NOX1 protein, mouse
  • Vascular Endothelial Growth Factor Receptor-2
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11